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At the site of infection, Th2 cells secrete
IL-13 upon exposure to IL-33. Minutti
et al. now show that TCR-induced
expression of the EGFR and its ligand
amphiregulin was essential for IL-33-
induced IL-13 secretion, revealing a
mechanism whereby antigen-specific
activation controls the innate effector
function of Th2 cells.c.
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Gastro-intestinal helminth infections trigger the
release of interleukin-33 (IL-33), which induces
type-2 helper T cells (Th2 cells) at the site of infection
to produce IL-13, thereby contributing to host resis-
tance in a T cell receptor (TCR)-independent manner.
Here, we show that, as a prerequisite for IL-33-
induced IL-13 secretion, Th2 cells required the
expression of the epidermal growth factor receptor
(EGFR) and of its ligand, amphiregulin, for the forma-
tion of a signaling complex between T1/ST2 (the IL-
33R) and EGFR. This shared signaling complex
allowed IL-33 to induce the EGFR-mediated activa-
tion of theMAP-kinase signaling pathway and conse-
quently the expression of IL-13. Lack of EGFR
expression on T cells abrogated IL-13 expression in
infected tissues and impaired host resistance.
EGFR expression on Th2 cells was TCR-signaling
dependent, and therefore, our data reveal a mecha-
nism by which antigen presentation controls the
innate effector function of Th2 cells at the site of
inflammation.
INTRODUCTION
Cytokines secreted at the site of infection crucially contribute to
protective immunity against gastro-intestinal helminth infec-
tions (Anthony et al., 2007; Grencis, 2015). These cytokines
induce diverse local effector functions that range from
enhanced migration and turnover of intestinal epithelial cells
(IECs), enhanced smooth muscle contractility, and local goblet
cell hyperplasia to the induction of effector molecules such
as the resistin-like molecules RELM alpha and beta or the710 Immunity 47, 710–722, October 17, 2017 ª 2017 The Author(s). P
This is an open access article under the CC BY license (http://creativede novo expression of the mucin Muc5ac, which has a direct
detrimental effect on nematode vitality (Anthony et al., 2007;
Hasnain et al., 2011). Which specific effector functions mediate
pathogen-specific host resistance is dependent on the type
of parasite, the physical location of the parasite within the
gastro-intestinal tract, and the stage of infection (Anthony
et al., 2007).
Cells at the site of infection that produce cytokines may be
part of the innate immune system, such as type-2 innate
lymphoid cells (ILC2), as well as of the adaptive immune sys-
tem, such as pathogen-specific type-2 helper T cells (Th2 cells).
ILC2, resident within mucosal tissues, can rapidly secrete cyto-
kines upon exposure to interleukin-33 (IL-33) in an antigen-inde-
pendent manner and, as demonstrated by adoptive transfer of
in-vitro-expanded ILC2, can directly contribute to host resis-
tance (Moro et al., 2010; Neill et al., 2010; Saenz et al., 2010).
By contrast, pathogen-specific Th2 cells need first to be
primed in an antigen-dependent manner, clonally expand, and
migrate to the site of infection before they can contribute to
nematode expulsion. Nevertheless, during gastro-intestinal
helminth infections, Th2 cells rapidly outnumber ILC2 at the
site of infection (Guo et al., 2015), and a number of publications
suggest that these Th2 cells directly contribute to pathogen
clearance (Anthony et al., 2006; Urban et al., 1992; Zaiss
et al., 2006).
Although cytokine production by T cells is closely controlled
by antigen-dependent T cell receptor (TCR) activation (Slifka
and Whitton, 2000), it has recently been shown that Th2 cells
can directly contribute to host resistance in a TCR-independent
manner, by secreting the type-2 effector cytokine IL-13 upon
exposure to IL-33 (Guo et al., 2015, 2009). This antigen-indepen-
dent potential of Th2 cells to produce cytokines raises the ques-
tion to which extent both antigen-dependent and -independent
Th2 cell effector functions contribute to host resistance and
whether these two functions are integrated.
We have shown before that activated effector CD4 T cells ex-




Figure 1. EGFR Expression by T Cells Contributes to Host Resistance against Gastro-intestinal Helminth Infections
(A–C) WT, Egfrfl/fl, and Egfrfl/flxCd4-cre (EGFRDCD4) mice were infected with H. polygyrus or N. brasiliensis or left untreated. Percentage and absolute number of
EGFR expressing CD4+ T helper cells in (A) duodena, (B) mLN, and (C) spleen, and EGFR expression on total CD4+ and CD69+ and CD69– mLN-derived T cells
from naive or H. polygyrus-infected mice was determined by flow cytometry analysis on day 14 post infection.
(D) Comparison of GATA3 expression on CD4+ T cells from mLN and spleen of H. polygyrus-infected Egfrfl/fl and EGFRDCD4 mice.
(E) Time-dependent egg load in feces and worm burden 4 weeks post infection with H. polygyrus (n = 4 mice).
(F) Time-dependent egg load in feces and worm burden 9 days post infection with N. brasiliensis (n = 3 mice).
All data are representative of at least two independent experiments (mean ± SEM); results for individual mice are shown as dots. See also Figures S1–S3.2013). Here, we demonstrate that EGFR expression on Th2 cells
was of critical importance for host resistance during gastro-in-
testinal helminth infections. Only following the induction of
EGFR expression and the amphiregulin (AREG)-dependent for-
mation of a functional signaling complex between the EGFR
and T1/ST2 (the IL-33R) could activated Th2 cells secrete IL-
13 in an antigen-independent way upon exposure to IL-33.
EGFR expression by Th2 cells was induced by antigen-mediated
activation. Thus, via the expression of the EGFR, TCR-mediated
activation licenses Th2 cells to respond in an innate-like fashion,
while at the same time controlling the overall immune response in
an antigen-specific manner.RESULTS
EGFR Expression by Activated Th2 Cells Contributes to
Host Resistance
Since CD4+ effector T cells can express the EGFR (Liao et al.,
2008; Zaiss et al., 2013), we explored whether Th2 cells might
express the EGFR during helminth infections and whether
EGFR expression contributes to host resistance. While we found
negligible EGFR expression on CD4+ T cells from uninfected
mice, EGFR expression was upregulated onCD4+ T cells derived
from the duodena (Figure 1A) and mesenteric lymph nodes
(mLN) (Figure 1B) of mice infected with the gastro-intestinalImmunity 47, 710–722, October 17, 2017 711
helminth Heligmosomoides polygyrus. EGFR expression was
restricted to recently activated CD4+ T cells, as defined by the
co-expression of the activation marker CD69 (Figure 1B). In
contrast to mLN, the frequency of EGFR positive CD4+ T cells
in the spleen was lower (Figure 1C), although a comparable frac-
tion of CD4+ T cells expressed the Th2 transcription factor
GATA3 in both lymphoid organs (Figure 1D).
To determine the physiological relevance of EGFR expression
on T cells, we generated a mouse strain that lacks EGFR expres-
sion in T cells by crossing Cd4-cre mice onto an Egfrfl/fl back-
ground. Uninfected Egfrfl/flxCd4-cre mice showed no signs of
immune dysregulation, and T cell development appeared normal
(Zaiss et al., 2013; Figure S1). However, Egfrfl/flxCd4-cremice in-
fected with the gastro-intestinal helminth H. polygyrus showed
significantly higher egg burdens and worm clearance was de-
layed significantly in comparison to infected wild-type (WT) con-
trol mice (Figure 1E). Similar results were obtained when
Egfrfl/flxCd4-cre mice were infected with Nippostrongylus brasi-
liensis, another gastro-intestinal nematode (Figure 1F).
Immunity to gastro-intestinal helminth infections is closely
related to the expansion and function of regulatory T (Treg) cells
(Allen andMaizels, 2011; Smith et al., 2016). Since Treg cell func-
tion is closely regulated by EGFR expression (Nosbaum et al.,
2016; Okoye et al., 2014; Zaiss et al., 2013), we rationalized
that Treg cell dysfunction may explain the enhanced susceptibil-
ity of Egfrfl/flxCd4-cremice to helminth infection. However, mice
with a Treg cell-specific EGFR deficiency (Foxp3-cre x Egfrfl/fl)
clearedH. polygyrus as efficiently asWTcontrolmice (Figure S2),
suggesting that EGFR expression on Treg cells did not
contribute to the enhanced susceptibility of Egfrfl/flxCd4-
cre mice.
In order to determine the cause for the enhanced susceptibility
of Egfrfl/flxCd4-cre mice to helminth infections, we analyzed the
immune response of WT and Egfrfl/flxCd4-cre mice to
H. polygyrus infection in more detail (Figure S3). We observed
that percentages of CD4+ T cells and their ability to produce IL-
13 upon in vitro re-stimulation were comparable in both strains
(Figure S3B). Pathogen-specific antibody titers within the serum
and faeces were unaffected by a lack of EGFR expression on
T cells (Figure S3C). Furthermore, we found similar frequencies
of ILC2 in the mLN of infected Egfrfl/flxCd4-cre and WT control
mice, and their capacity to produce type-2 cytokines upon IL-
33 exposure was unaffected (Figure S3D), indicating that a lack
of EGFR expression on T cells does not fundamentally affect
ILC2 expansion and function. Furthermore, in-vitro-generated
Th2 cells from Egfrfl/flxCd4-cre and WT mice expressed type-2-
specific transcription factors GATA-3, c-MAF, and STAT-6 (Fig-
ure S3E), showed no major transcriptional deviations from each
other (Figure S3E), and expanded similarly (Figure S3E).
From these data we conclude that EGFR expression on CD4+
T cells is critical for Th2 cell-mediated host resistance to
gastro-intestinal helminth infections. Nevertheless, a lack of
EGFR expression does not induce a fundamental dysfunction
of Th2 cells.
IL-13 Production at the Site of Infection Is Dependent on
EGFR Expression by T Cells
One central component of host resistance against helminth in-
fections is the expression of the effector cytokine IL-13 (Guo712 Immunity 47, 710–722, October 17, 2017et al., 2015; McKenzie et al., 1998). H. polygyrus larvae are
particularly sensitive to IL-13-induced effector mechanism
from day 7 until day 9 post infection, when they leave the gut mu-
cosa in order to reside in the intestinal lumen (Reynolds et al.,
2012). We therefore determined cytokine production at the site
of infection during this stage of infection. We found that Il13
mRNA expression in the duodenum was significantly lower in in-
fected Egfrfl/flxCd4-cre mice in comparison to WT mice (Fig-
ure 2A). This deficiency in cytokine expression was specific for
IL-13, since the expression of Il5 and Il4 mRNA (Figure 2A) and
the influx of T cells into the duodenum (Figure 2A) were unaf-
fected. In contrast to the site of infection, Il13mRNA expression
within the draining mLN was similar in both mouse strains (Fig-
ure S4A). Strikingly, the diminished message for Il13 in the
duodena of Egfrfl/flxCd4-cre mice directly correlated with a lack
of Muc5ac expression (Figure 2B), an IL-13-induced mucin that
directly affects gastro-intestinal nematode vitality (Hasnain
et al., 2011).
In order to determine the cellular source of IL-13 at the site
of infection, we injected brefeldin A into mice infected with
H. polygyrus, at day 7 post infection. We harvested the duo-
denum 6 hr later and purified intestine-residential leukocytes in
the presence of monensin. Since brefeldin A and monensin pre-
vent the secretion of cytokines, this approach allowed us to
directly reveal which cells expressed effector cytokines within
the duodenum of infected mice. As shown in Figure 2C, CD4+
T cells but not ILC2 expressed detectable amounts of IL-13 at
this stage of infection. In addition, only CD4+ T cells in infected
WT but not in Egfrfl/flxCd4-cre mice expressed IL-13, while
CD4+ T cells frombothmouse strains expressed similar amounts
of IL-5 (Figures 2C, S4B, and S4C). Also, the numbers of CD4+
T cells and ILC2 recovered from the infected duodenawere com-
parable for both mouse strains (Figure S4D).
To confirm that a lack of IL-13 expression could be the
cause of diminished worm clearance, we injected rIL-13 into
Egfrfl/flxCd4-cre mice at days 6, 7, and 8 post infection. Supple-
mentation of IL-13 at this stage of infection resulted in signifi-
cantly lower egg counts and worm burdens in infected
Egfrfl/flxCd4-cremice, fully reverting their susceptible phenotype
(Figure 2D). Furthermore, the transfer of CD4+ T cells derived
from infected WT but not from Egfrfl/flxCd4-cre donors restored
host resistance of IL-13-deficient mice toH. polygyrus infections
(Figure 2E). Similarly, transfer of purified CD4+ T cells from
H. polygyrus-infected WT donors into infected Egfrfl/flxCd4-cre
mice significantly diminished egg output in Egfrfl/flxCd4-cre
recipient mice (Figure 2F), whereas transfer of purified CD4+
T cells from Egfrfl/flxCd4-cre donors did not.
Taken together, our data show that a lack of EGFR expres-
sion on T cells leads to diminished T cell-derived IL-13 expres-
sion in the duodenum at the time point when H. polygyrus
worms establish themselves in the gut lumen. Diminished IL-
13 expression at this stage of infection correlated with dimin-
ished Muc5ac expression and a defect in worm clearance,
while application of recombinant IL-13 or transfer of CD4+
T cells from infected WT mice was sufficient to restore worm
clearance. Consequently, the lack of IL-13 expression by
CD4+ T cells at the site of infection is likely to be causative






Figure 2. IL-13 Production at the Site of Infection Is Dependent on EGFR Expression by T Cells
WT, Egfrfl/fl, and Egfrfl/flxCd4-cre (EGFRDCD4) mice were infected with H. polygyrus or left untreated.
(A–C) At day 8 post infection (A) Il13, Il5, Il4, Cd3e, and (B)Muc5acmRNA was analyzed in the duodena by RT-PCR. (C) Mice were treated with BFA 6 hr prior to
harvest, after which, single-cell suspensions from duodena of naive or infected mice were prepared and analyzed by flow cytometry: percentage and absolute
number of IL-13-expressing T cells (left) and ILC2 (right).
(D) H. polygyrus-infected EGFRDCD4 mice received either PBS or IL-13 at days 6, 7, and 8 post infection, and egg counts were analyzed 2 weeks later.
(E) Flow cytometry-sorted mLN-derived CD4+ T cells were transferred from naive or H. polygyrus-infected Egfrfl/fl or EGFRDCD4 mice into infected (day 7 post
infection) recipient Il13/ mice, and eggs were counted in feces 2 weeks later; egg load on a WT strain is shown for reference.
(F) mLN-derived CD4+ T cells were transferred from naive or H. polygyrus-infected Egfrfl/fl or EGFRDCD4 mice into infected (day 7 post infection) recipient
EGFRDCD4 mice, and eggs were counted in feces 2 weeks later.
All data are representative of at least two independent experiments (mean ± SEM); results for individual mice are shown as dots. See also Figure S4.
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Figure 3. IL-33-Induced IL-13 Production by Th2 Cells Is Dependent on EGFR Expression
WT, Egfrfl/fl, and Egfrfl/flxCd4-cre (EGFRDCD4) mice were infected with H. polygyrus, and on day 14 post infection, mLN were harvested.
(A) Comparison of T1/ST2 expression on mLN CD4+ T cells from H. polygyrus-infected Egfrfl/fl and EGFRDCD4 mice.
(B) mLN cells were stimulated with rIL-33, anti-CD3, or media only, and expression of IL-13 and IL-5 was determined by intra-cellular cytokine staining and flow
cytometry analysis.
(C) mLN CD4+ T cells from H. polygyrus-infected WT mice were flow cytometry-sorted based on T1/ST2 and/or EGFR expression, and T cell populations were
stimulated with rIL-33 for 4 hr. Subsequently, Il13 and Il5 mRNA was analyzed by RT-PCR.
(D) MHCII-deficient mice were infected with H. polygyrus and 7 days post infection received CD4+ T cells derived frommLN of naive or H. polygyrus-infected WT
or EGFRDCD4 mice. Worm burden and egg counts were determined 2 weeks post infection.
(E–G) MHCII-deficient mice were infected with N. brasiliensis and simultaneously received CD4+ T cells from mLN of naive (WT) or H. polygyrus-infected WT,
EGFRDCD4, or T1/ST2-deficient mice, collected 2 weeks after infection. At day 6 post transfer, worm burden and eggs counts (E) were determined, IL-13 and IL-5
(F) expression in BAL was evaluated by ELISA, and expression of Ym1 in alveolar macrophages and total number of eosinophils in the BAL (G) were analyzed by
flow cytometry.
Data are representative of two independent experiments (mean ± SEM); results for individual mice are shown as dots.IL-33-Induced IL-13 Production by Th2 Cells Is
Dependent on EGFR Expression
IL-13 expression by Th2 cells can either be induced by TCR acti-
vation or in an antigen-independent way by exposure to IL-33
(Guo et al., 2009). In order to determine whether a lack of respon-
siveness to IL-33 by Th2 cells explained the diminished IL-13714 Immunity 47, 710–722, October 17, 2017expression in Egfrfl/flxCd4-cre mice, we determined IL-13
expression by CD4+ T cells derived from mice infected with
H. polygyrus ex vivo. Despite similar expression of the IL-33
receptor T1/ST2 (Figure 3A), CD4+ T cells derived from
H. polygyrus-infected Egfrfl/flxCd4-cre mice failed to express
IL-13 upon exposure to IL-33. However, IL-33-induced IL-5
and IL-13 expression upon anti-CD3 stimulation was unaffected
(Figure 3B). These data demonstrate that Th2 cells of
Egfrfl/flxCd4-cre mice are capable of producing IL-13 upon
antigen-specific stimulation but fail to produce IL-13 in response
to IL-33.
To determinewhether theremight be a link between EGFR and
T1/ST2 expression, we flow cytometry-sorted activated CD4+
T cells (CD69+) derived from the mLN of H. polygyrus-infected
mice based on T1/ST2 and/or EGFR expression. As shown in
Figure 3C, the induction of IL-13 in response to IL-33 exposure
was restricted to the double-positive population, whereas IL-5
induction was dependent on T1/ST2 expression only. These
findings demonstrate that T1/ST2-expressing Th2 cells require
EGFR expression in order to produce IL-13 upon IL-33 exposure.
To address whether the previously described TCR-indepen-
dent and IL-33-dependent capacity of Th2 cells to contribute
to host resistance to helminth infections (Guo et al., 2015) re-
quires EGFR expression, we transferred mLN-derived CD4
T cells from H. polygyrus-infected Egfrfl/flxCd4-cre or WT mice
into H. polygyrus-infected major histocompatibility complex
(MHC)-II-deficient mice, at day 7 post infection. While transfer
of WT cells significantly diminished worm burden, transfer of
cells derived from infected Egfrfl/flxCd4-cre mice did not (Fig-
ure 3D). Thus, the innate capacity of Th2 cells to contribute to
worm expulsion is directly dependent on EGFR expression.
Furthermore, we decided to determine how the expression of
EGFR on Th2 cells influences their innate-like cytokine expres-
sion within secondary inflamed tissues. To this end, we trans-
ferred purified CD4+ T cell derived from the mLN of
H. polygyrus-infected mice into N. brasiliensis-infected MHC-II-
deficient mice. While H. polygyrus exclusively infects the gas-
tro-intestinal tract, N. brasiliensis larvae migrate through the
lung on route to intestine colonization, leaving behind a strong in-
flammatory environment. Transfer of purified CD4+ T cells
derived from H. polygyrus-infected WT mice into N. brasilien-
sis-infected MHC-II-deficient mice led to a significant reduction
in worm burdens (Figure 3E). In contrast, transfer of CD4+
T cells from infected Egfrfl/flxCd4-cre or T1/ST2-deficient mice
did not (Figure 3E).
Of note, N. brasiliensis-infected MHC-II-deficient mice that
had received CD4+ T cells derived from H. polygyrus-infected
WT mice showed significantly elevated IL-13 and IL-5 expres-
sion in the bronchoalveolar lavage (BAL) (Figure 3F). In contrast,
MHC-II-deficient mice that had received CD4+ T cells derived
from Egfrfl/flxCd4-cre mice showed elevated IL-5 but lower IL-
13 expression (Figure 3F). MHC-II-deficient mice that had
received CD4+ T cells derived from H. polygyrus-infected T1/
ST2-deficient mice lacked detectable quantities of either cyto-
kine (Figure 3F). Consistent with these cytokine expression pro-
files, alveolar macrophages from mice that received WT CD4+
T cells showed enhanced expression of Ym1 (Figure 3G), a
marker of alternative activation of macrophages that can be
induced through IL-13 signaling via the IL-4Ra chain. However,
mice that received either T1/ST2-deficient or EGFR-deficient
CD4+ T cells failed to induce alternative activation of alveolar
macrophages (Figure 3G). In contrast to macrophage skewing,
expansion of eosinophils in the BAL of N. brasiliensis-infected
MHC-II-gene-deficient mice, a process dependent on IL-5
expression, was enhanced in mice that received WT or EGFR-deficient CD4+ T cells but was absent in mice that received T1/
ST2-deficient CD4+ T cells (Figure 3G).
Taken together, our data demonstrate that EGFR expression
by Th2 cells regulates their antigen-independent cytokine
expression in response to IL-33.
InducedEGFRExpression Licenses Th2Cells to Express
IL-13 in an Innate-like Way
Next, we wanted to determine which factors influence EGFR
expression on Th2 cells. In contrast to Th2 cells derived from
the duodenum and mLN of infected mice, Th2 cells derived
from the spleen of H. polygyrus-infected mice had lower EGFR
expression (Figure 1A–1C). We therefore used splenic CD4+
T cells fromH. polygyrus-infected mice to determine which stim-
uli induce EGFR expression on CD4+ T cells. We stimulated
these cells overnight with either cytokines or via the TCR, using
antigen-specific stimulation or activating anti-CD3 antibody.
Stimulation through the TCR induced EGFR expression in
CD4+ T cells (Figure 4A). In addition, as described before (Liao
et al., 2008), exposure to cytokines that induce STAT5 signaling,
such as IL-2, IL-7, or TSLP, also induced EGFR expression in
CD4+ T cells; however, exposure to IL-33 did not (Figure 4A).
In accordance with EGFR expression, overnight exposure to
TSLP, a cytokine expressed at sites of helminth infection (Taylor
et al., 2009), restored the capability of WT but not Egfrfl/flxCd4-
cre splenic T cells from H. polygyrus-infected mice to produce
IL-13 in response to IL-33 (Figure 4A), demonstrating that
induced EGFR expression licenses Th2 cells to produce IL-13
upon exposure to IL-33.
In addition to the induction of EGFR expression, we also
wanted to know for how long Th2 cells remain responsive to
IL-33 and whether this sensitivity would correlate with EGFR
expression. While T1/ST2 expression on activated Th2 cells is
known to be stable (Lo¨hning et al., 1998), the duration of EGFR
expression on activated Th2 cells remains unknown. To address
EGFR stability, we transferred activated Th2 cells from
H. polygyrus-infected WT mice into naive mice (Figure 4B) or,
alternatively, induced worm clearance by administering a de-
worming drug (Figure 4C). As shown in Figure 4, EGFR expres-
sion on activated Th2 cells dropped rapidly upon transfer from
infected Ly5.2 mice into uninfected Ly5.1 mice or upon drug-
mediatedworm expulsion. This drop in EGFR expression directly
correlated with a loss of capacity of Th2 cells to produce IL-13
upon IL-33 exposure (Figures 4B and 4C). In contrast, the capac-
ity of these cells to produce IL-5 upon exposure to IL-33
remained unimpaired, which directly correlated with the unaf-
fected T1/ST2 expression on Th2 cells (Figures 4B and 4C).
Taken together, these data demonstrate that EGFR expres-
sion on Th2 cells is only transient and rapidly lost in the absence
of inflammation.
Antigen-Independent Function of Th2 Cells Requires
Antigen-Induced EGFR Expression
Our data show that cytokines, such as TSLP, can induce EGFR
expression in CD4+ T cells derived from H. polygyrus-infected
mice. Therefore, we wanted to determine whether, under physi-
ological conditions, EGFR expression on Th2 cells can be driven
by cytokine-induced bystander activation or at one point has to
be controlled by antigen presentation. To this end, we comparedImmunity 47, 710–722, October 17, 2017 715
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Figure 4. Transient EGFR Expression Licenses Th2 Cells to Express IL-13 in Response to IL-33
(A) Splenocytes were isolated from H. polygyrus-infected WT and Egfrfl/flxCd4-cre (EGFRDCD4) mice, and expression of EGFR on T cells was determined by flow
cytometry analysis after overnight incubation with H. polygyrus excretory-secretory products (HES), adult worm extract (HEX), anti-CD3, vehicle (C), rIL-7, rIL-2,
rTSLP, or rIL-33 (upper). Alternatively (lower), splenocytes were stimulated overnight with rTSLP, and subsequently, IL-13 expression by T cells was analyzed by
intra-cellular cytokine staining and flow cytometry analysis following re-stimulation with rIL-33 or anti-CD3 antibody.
(B) Ly5.2+ WT mice were infected with H. polygyrus, and 2 weeks after infection, mLN cells were transferred into naive Ly5.1+ hosts. Spleens of recipient mice
were harvested after 0–3.5 days post transfer, and the expression of EGFR (upper) and T1/ST2 (lower) on transferred Ly5.2+ CD4+ T cells was determined by flow
cytometry analysis. Expression of IL-13 (upper) and IL-5 (lower) upon exposure to rIL-33 was determined by intra-cellular cytokine expression and flow cytometry
analysis (n = 3 mice).
(C) WT H. polygyrus-infected mice were treated with pyrantel embonate, and mLN were harvested after 0–6 days post treatment. EGFR (upper) and T1/ST2
(lower) expression on CD4+ T cells was determined by flow cytometry, and expression of IL-13 (upper) and IL-5 (lower) upon exposure to IL-33 was determined by
intra-cellular cytokine staining and flow cytometry analysis (n = 3 mice).
Data are representative of at least two independent experiments (mean ± SEM); results for individual mice are shown as dots. Data in (B) and (C) are presented as
percentage of expression on day 0.EGFR expression on mLN-derived CD4+ T cells from H. polygy-
rus-infected mice or memory CD4+ T cells from drug-treated
mice. Figure 5A shows that, whereas recently activated CD4+
T cells increase EGFR expression, memory cells do not. Thus,
we sorted memory cells (CD45RBlowCD25–CD44high) and acti-
vated Th2 cells (CD69+ST2+) based on EGFR expression (Fig-
ure 5B) and either exposed these cell populations directly to
IL-33 or cultured memory and activated EGFR– CD4+ T cells in
the presence of CD3-stimulating antibodies or TSLP overnight.
We observed that EGFR-expressing activated Th2 cells readily
expressed IL-13 upon IL-33 exposure, while memory CD4+
T cells did not (Figure 5C). Furthermore, we observed that
TCR-mediated activation and TSLP stimulation could induce
EGFR expression in the activated cell population that were iso-
lated based on a lack of EGFR expression; however, CD4+
T cells within the memory population expressed EGFR only
upon TCR-mediated activation, while TSLP alone was insuffi-
cient to induce EGFR expression (Figure 5D). Furthermore, the
capability of the different sorted cell populations to express IL-
13 in response to IL-33 was directly correlated to EGFR expres-
sion (Figure 5E).
In order to address the in vivo relevance of antigen presenta-
tion for the re-activation of memory CD4+ T cells, we transferred716 Immunity 47, 710–722, October 17, 2017CD4+ T cells into MHC-II-deficient mice. Transferred cells were
either derived from infected mice or from mice that had been
drug-treated 2 weeks prior to transfer. While CD4+ T cells from
infected mice significantly diminished worm burden, transfer of
CD4+ T cells from drug-treated mice did not (Figure S5A). How-
ever, transfer of CD4+ T cells from dewormed WT mice was
sufficient to induce worm expulsion in infected Egfrfl/flxCd4-cre
recipients (Figure S5B), suggesting that antigen-specific re-acti-
vation enabled the transferred resting Th2 cells to contribute to
worm expulsion.
In order to exclude possible variations in numbers of trans-
ferred T cells, we modified the previous experimental approach
and immunized WT and Egfrfl/flxCd4-cre mice with ovalbumin
(OVA) and subsequently repeatedly challenged these mice with
OVA intra-nasally. We then harvested thoracic lymph nodes
and sorted activated T cells immediately after challenge or mem-
ory CD4+ T cells 4 weeks post challenge, and equal number of
memory or activated CD4+ T cells were transferred into
H. polygyrus-infected Egfrfl/flxCd4-cre recipient mice. As shown
in Figure 5F, transfer of activated WT but not Egfrfl/flxCd4-cre
CD4+ T cells induced worm expulsion. Memory CD4+ T cells,
however, were not able to provide protection unless recipient




Figure 5. EGFR Expression on Th2 Cells Is
Induced by TCR Activation and Maintained
by Cytokines
(A–E) WT H. polygyrus-infected mice were either
treated with pyrantel embonate or left untreated;
mLN were collected 14 days after treatment.
(A) EGFR expression on activated (CD69+, red
bars) or memory (CD25–CD45RBlowCD44hi, blue
bars) CD4+ T cells was analyzed by flow cy-
tometry.
(B) Activated CD4+ T cells were flow cytometry-
sorted from infected mice into ST2+ EGFR+ (red)
and ST2+ EGFR– (orange) populations. Memory
CD4+ T cells (CD25–CD45RBlowCD44hi) were flow
cytometry-sorted from dewormed mice.
(C) After sorting, activated EGFR+ and memory
cells were stimulated with rIL-33 or media only,
and expression of IL-13 was determined by flow
cytometry analysis.
(D–E) Activated EGFR– and memory cells were
cultured overnight with rTSLP or anti-CD3 anti-
bodies, and expression of EGFR on CD4+ T cells
was determined by flow cytometry analysis (D) or
were re-stimulated with rIL-33 and expression of
IL-13 determined by intra-cellular cytokine stain-
ing and flow cytometry analysis (E).
(F–G) Egfrfl/flxCd4-cre (EGFRDCD4) mice were in-
fected with H. polygyrus and received either flow
cytometry-sorted activated CD4 T cells (red) (F) or
flow cytometry-sorted naive or memory T cells
(blue) (G) from OVA-challenged mice. Worm
burden and egg counts in feces were determined
2 weeks post transfer.
Data in (A)–(E) are representative of at least two
independent experiments (mean ± SEM); results
for individual mice are shown as dots. See also
Figure S5.expulsion directly correlated with the presence of EGFR-ex-
pressing CD4+ T cells within the duodenum (Figure S5C).
Taken together, these experiments show that only antigen-
specific activation of Th2 cells induces EGFR expression, while
cytokines maintain EGFR expression in recently activated
Th2 cells.
T1/ST2 and EGFR Form a Common Signaling Complex
on Th2 Cells
Finally, we wanted to determine the mechanism by which EGFR
expression controls IL-33-induced cytokine expression. IL-13
expression is critically dependent on ERK activation (Pahl
et al., 2002), and because MAP-kinase signaling is one of the
principal pathways induced by EGFR activation, we hypothe-
sized that EGFR-mediated activation of MAP-kinase signaling
may facilitate IL-33 to induce IL-13 expression in Th2 cells. In
accordance with this hypothesis, IL-33 failed to induce ERK
phosphorylation in EGFR-deficient CD4+ T cells (Figure 6A),
and treatment of T cells derived from H. polygyrus-infected
WT mice with MEK inhibitors, which interfere with the MAP-ki-Immnase signaling pathway, phenocopied
Egfrfl/flxCd4-cre T cells (Figure S6A). IL-
33-induced IL-5 and IL-4 expression
(Figure S6B) as well as IkBa degradation(Figure S6B) were unaffected by a lack of EGFR expression. This
finding is in accordance with the fact that IL-5 expression is
dependent on p38 but not on ERK activation (Endo et al.,
2015). Accordingly, IL-33-induced IL-5 expression was unaf-
fected by MEK inhibitor treatment (Figure S6C). These data
demonstrate that specifically IL-33-induced ERK activation is
EGFR dependent, while other signaling pathways downstream
of T1/ST2 are not.
In order to induce EGFR signaling upon IL-33 exposure, T1/
ST2 could either form an active signaling complex together
with the EGFR, or T1/ST2 could induce the expression or release
of EGFR ligands that then indirectly activate the EGFR.
To address these possibilities, we first exposed CD4+ T cells
derived from H. polygyrus-infected mice with IL-33 in the pres-
ence of the EGFR inhibitor gefitinib and the pan-metalloprotease
inhibitor marimastat, which disrupts the release of newly ex-
pressed EGFR ligands from the cell surface. EGFR inhibition
prevented IL-33-induced IL-13 production and ERK phosphory-
lation (Figures 6B and 6C), while the inhibition of EGFR trans-






Figure 6. IL-33-Induced IL-13 Production by
Th2 Cells Is Dependent on a Signaling Com-
plex between T1/ST2 and EGFR
WT and Egfrfl/flxCd4-cre (EGFRDCD4) mice were in-
fected with H. polygyrus larvae, and on day 14 post
infection, mLN were harvested.
(A–C) Cells were stimulated with rIL-33, anti-CD3, or
media in the presence of gefitinib, marimastat, or
vehicle, and p-ERK (A and C) or IL-13 (B) expression
was determined by intra-cellular staining and flow
cytometry analysis.
(D and E) Cells were stimulated with rHB-EGF, anti-
CD3, or media, and IL-13 (D) and p-ERK (E)
expression was determined by intra-cellular stain-
ing and flow cytometry analysis.
(F) EGFR expression on stimulated mLN WT CD4+
T cells in the presence of monensin was analyzed by
flow cytometry.
(G) HEK293T cells were transfected as indicated
with T1/ST2, the IL-1RacP, or the EGFR alone or in
combination. Subsequently, the cells lysates were
analyzed for the expression of the transfected pro-
teins (input, left panel). The same lysates were also
subjected to an EGFR-specific immunoprecipita-
tion (EGFR-IP, right panel) or were treated with the
isotype control (iso, right panel). Precipitates were
analyzed by immunoblot.
(H) mLN (upper) or HaCaT cells (lower) were stimu-
lated with rIL-33, rHB-EGF, or media, and the EGFR
phosphorylation at position Y1068 was determined
by intra-cellular staining and flow cytometry anal-
ysis (upper) or immunoblot (lower).
All data are representative of at least two indepen-
dent experiments (mean ± SEM); results for indi-
vidual mice are shown as dots. See also Figure S6.IL-13 expression nor on ERK phosphorylation (Figures 6B and
6C). Furthermore, we observed that the high-affinity EGFR ligand
HB-EGF was not able to induce IL-13 expression by CD4+ T cells
despite inducing ERK activation in these cells (Figures 6D and
6E), indicating that IL-33-induced IL-13 expression is not medi-
ated by the release of EGFR ligands.
To address whether both receptors may physically interact,
we studied the internalization of the EGFR on IL-33-treated
CD4+ T cells derived from H. polygyrus-infected mice in
the presence of monensin. Monensin allows for activation-
induced internalization of trans-membrane receptors but pre-718 Immunity 47, 710–722, October 17, 2017vents re-circulation of these receptors
back to the cell surface. As shown in Fig-
ure 6F, IL-33 induced the internalization
of the EGFR. This activation-induced
internalization was specific for IL-33
exposure and not observed upon TCR-
mediated stimulation (Figure 6F). Addi-
tionally, EGFR co-immunoprecipitated
with T1/ST2 and its associated signaling
molecules, such as SOS and Shp-2,
when co-expressed in HEK cells (Fig-
ure 6G). Similarly, EGFR co-immunopre-
cipitated with T1/ST2 from IL-33-treated
CD4+ T cells derived from H. polygyrus-in-
fected WT but not from Egfrfl/flxCd4-cremice (Figure S6D), further suggesting that both receptors may
form a shared complex.
EGFR-induced activation of the MAP-kinase signaling
pathway is mediated via the phosphorylation of Tyr-1068.
Thus, we wanted to test whether IL-33 may induce Tyr-1068 of
the EGFR. As shown in Figure 6H, IL-33 induced the rapid phos-
phorylation of Tyr-1068 in CD4+ T cells derived from
H. polygyrus-infected mice (Figure 6H) as well as in HaCat cells
(Figure 6H).
Based on these data, we conclude that, similar to the reported
interaction between T1/ST2 and c-kit on mast cells (Drube et al.,
2010), T1/ST2 forms an active signaling complex with the EGFR
on Th2 cells, which enables IL-33 to activate the MAP-kinase
signaling pathway and induce ERK phosphorylation and conse-
quently IL-13 expression.
Formation of a Common Signaling Complex Is
Dependent on Th2 Cell-Derived Amphiregulin
Another important type-2 cytokine and EGF-like growth factor
is AREG (Zaiss et al., 2015). Similar to that of EGFR (Figure 4A),
AREG expression in Th2 cells is also induced by TCR and
TSLP, but not IL-33 (Figure S7A). We have shown that Th2
cell-derived AREG enhances the clearance of the gastro-intes-
tinal helminth Trichuris muris (Zaiss et al., 2006), and we there-
fore asked whether this EGF-like growth factor contributes to
IL-33-induced IL-13 production. Using Areg/ mice, we found
that IL-33 could not induce IL-13 expression and ERK activa-
tion in CD4+ T cells derived from the mLN of H. polygyrus-in-
fected mice (Figure 7A and 7B), although EGFR expression
on Th2 cells and the fraction of CD4+ T cells expressing the
EGFR were similar in WT as in Areg/ mice (Figure S7B).
Also, IL-33-induced IL-5 expression was unaffected (Fig-
ure S7C). Moreover, transfer of CD4+ T cells derived from
H. polygyrus-infected Areg/ mice could not induce worm
expulsion in MHC-II-deficient mice (Figure 7C), suggesting
that Th2 cell-derived AREG contributes to worm expulsion in
an autocrine fashion, enabling Th2 cells to function in an
innate-like manner.
Mechanistically, we found that in activated Th2 cells derived
from H. polygyrus-infected Areg/ mice, IL-33 could only
induce phosphorylation of Tyr-1068 of the EGFR in the pres-
ence of rAREG and thus ERK phosphorylation and IL-13
expression (Figure 7D–7F). Furthermore, in CD4+ T cells
derived from H. polygyrus-infected WT mice, position Tyr-992
of the EGFR is constitutively phosphorylated, while this
phosphorylation was missing in Areg/. Nevertheless, rAREG
could restore this phosphorylation (Figure 7G). Co-expression
and co-immunoprecipitation of an EGFR-Y992F mutant with
T1/ST2 in HEK cells further demonstrated that activation via
Tyr-992 of the EGFR is essential for the formation of a
hetero-complex between T1/ST2 and the EGFR (Figure 7H).
This finding was further supported by the fact that EGFR
co-immunoprecipitation (Figure S7D) and EGFR was co-inter-
nalized in the presence of monensin was enhanced in
response to IL-33 treatment on CD4+ T cells derived from
H. polygyrus-infected WT mice but not on CD4+ T cells derived
from H. polygyrus-infected Areg/ mice (Figure 7I). Taken
together, these data reveal that the AREG-induced Tyr-992
phosphorylation of the EGFR on Th2 cells allows for the
formation of an active signaling complex between the EGFR
and T1/ST2, essential for IL-33-induced IL-13 expression
(Figure S7E).
In conclusion, our data demonstrate that the innate-like
effector function of Th2 cells at the site of infection is controlled
by EGFR and AREG expression. In order to initiate their expres-
sion, Th2 cells require antigen-dependent activation, while their
expression on activated Th2 cells is sustained by cytokine-
induced signaling. In this way, TCR-mediated T cell activation
controls the innate effector function of Th2 cells via EGFR
expression.DISCUSSION
Several groups have shown before that Th2 cells contribute to
worm expulsion at the site of infection (Anthony et al., 2006;
Guo et al., 2015; Urban et al., 1992; Zaiss et al., 2006). These
findings raise the question of how Th2 cells are activated at the
site of infection. A number of cell types, such as macrophages,
endothelial cells, and ILC2, expressMHC-II molecules and could
therefore potentially present pathogen-derived antigens to Th2
cells. One well-established example for such an antigen-specific
interaction at the site of infection is theMHC-II-mediated interac-
tion between ILC2 and Th2 cells (Oliphant et al., 2014). Neverthe-
less, antigen presentation at the site of infection is inherently less
well organized thanwithin the site-draining lymph nodes. In addi-
tion, a number of helminths not only fundamentally change pro-
tein expression during development but also have been shown
to secrete products that directly interfere with antigen presenta-
tion (Carvalho et al., 2009), suggesting that local immune escape
mechanisms could limit the effectiveness of local antigen-based
cytokine expression. The group of W. Paul demonstrated that
Th2 cells, similar to ILC2, can function in an antigen-independent
way, by secreting the effector cytokine IL-13 upon exposure to
IL-33 (Guo et al., 2009). IL-33 release, however, is found under
a number of different inflammatory conditions. Thus, this TCR-
independent way of cytokine expression by Th2 cells raised
the question of how cytokine expression by Th2 cells might be
controlled to prevent aberrant expression of IL-13, which can
cause immune pathology and fibrosis (Wynn and Ramalingam,
2012). Our data reveal an unexpected mechanism by which
TCR-independent cytokine expression by Th2 cells is regulated.
Th2 cells are primed and expand in a clonal, antigen-dependent
manner. Once activated, Th2 cells upregulate EGFR expression
and express AREG, which allows them to secrete the effector
cytokine IL-13 following exposure to IL-33. Thus, in effect, via
this EGFR-mediated licensing of Th2 cells, we observed a func-
tional merger of the innate and adaptive immune responses at
the site of infection in order to reach a sufficient mass at critical
time points during infection. In this process, the involvement of
antigen-specific Th2 cells allows for the rapid expansion of cells
that can respond to infection independent of local antigen
presentation, while at the same time these cells remain in their
functional state closely controlled by antigen presentation,
thereby assuring for optimal host resistance while preventing
immunopathology.
Our finding that the interaction between T1/ST2 and the EGFR
is further controlled by the type-2 cytokine and EGF-like growth
factor AREG dovetails with our former findings demonstrating
that AREG contributes to the efficient clearance of Trichuris mu-
ris infection (Zaiss et al., 2006). In that publication, we showed
that Th2-derived AREG contributed to helminth expulsion by
enhancing the proliferation of the IEC layer at the site of infection.
These findings appeared to be in conflict with the findings by the
group of Richard Grencis, who had shown that the enhanced
proliferation of the IEC layer was IL-13 induced (Cliffe et al.,
2005). Our current data now show that Th2 cell-expressed
AREG in an autocrine fashion facilitates the IL-33-induced
expression of IL-13 at the site of infection. Thus, it is tempting
to speculate that also during T. muris infections, AREG may





Figure 7. AREG Induces EGFR Phosphorylation at Tyr-992, which Allows for the Interaction between T1/ST2 and EGFR
WT (gray) and Areg/ (purple) mice were infected with H. polygyrus, and on day 14 post infection, mLN were harvested.
(A and B)mLN cells were stimulated with rIL-33, anti-CD3, or media, and the IL-13 (A) and p-ERK (B) expressionwas determined by intra-cellular staining and flow
cytometry analysis.
(C) MHCII-deficient mice were infected with H. polygyrus and 7 days post-infection received flow cytometry-sorted CD4+ T cells derived from mLN of naive or
H. polygyrus-infected WT, Egfrfl/flxCd4-cre, or Areg/ mice. Worm burden and egg counts were determined 2 weeks post infection.
(D–F) mLN cells were stimulated with rIL-33, rAREG, both, or media only, and EGFR p-Y1068 (D), p-ERK (E), and IL-13 (F) expression was determined by flow
cytometry analysis.
(G) EGFR phosphorylation at position Y992 on CD4+ T cells derived frommLN of WT or Areg/H. polygyrus-infected mice in the presence or absence of rAREG.
(H) HEK293T cells were transfected as indicatedwith T1/ST2 and the IL-1RacP in combination withWTEGFR or EGFRY992Fmutant. Subsequently, the cell lysates
were analyzed for the expression of the transfected proteins (input, left panel). The same lysates were also subjected to an EGFR-specific immunoprecipitation
(EGFR-IP, right panel) or were treated with the isotype control (iso, right panel). Precipitates were analyzed by immunoblot.
(I) mLN cells were stimulated with rIL-33 in the presence of monensin, and EGFR expression on CD4+ T cells was analyzed by flow cytometry.
All data are representative of at least two independent experiments (mean ± SEM); results for individual mice are shown as dots. See also Figure S7.express IL-13 at the site of infection in an IL-33-dependent way.
This additional AREG-mediated control mechanism may further
restrict the interaction of both receptors to Th2 cells.
Finally, our findings further emphasize the importance of
signaling hetero-complexes between different cytokine receptor720 Immunity 47, 710–722, October 17, 2017families for the functioning of the immune system. T1/ST2 has
already been shown to form a signaling hetero-complex with
c-kit, another RTK, on mast cells (Drube et al., 2010). Thus,
despite the fact that the molecular mechanism by which T1/
ST2 interacts with these RTKs requires further, more detailed
analysis, it appears that signaling hetero-complexes composed
of trans-membrane receptors from different signaling families
are a more common phenomenon and may add another, so far
largely neglected layer of immune regulation. In particular, since
the EGFR is expressed on a wide range of leukocytes and since
our findings demonstrate that the EGFR can form hetero-com-
plexes with other cytokine receptors to regulate their signal
specificity, it is likely that the role of EGFR expression by leuko-
cytes in the functioning of the immune system is underestimated
to date. This notion is further supported by the observation that
cancer patients treated with EGFR antagonists suffer not only
from a wide range of side effects caused by loss of EGFR func-
tion on epithelial cells but also become more susceptible to in-
fections (Burtness et al., 2012).
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rat anti mouse CD4 (clone RM4-5) Biolegend Cat#100536
Armenian Hamster anti mouse CD69 (clone H1.2F3) Biologend Cat#104528
Anti mouse T1/ST2 (clone DJ8) MD Bioproducts Cat#101001B
Rat anti mouse CD62L (clone MEL-14) Biolegend Cat#104424
Rat anti CD44 (clone IM7) Biolegend Cat#103032
Rat anti mouse CD45Rb (clone 16A) BD PharMingen Cat#553101
Rat anti mouse CD25 (clone PC61) Biolegend Cat#102016
Mouse anti mouse CD45.1 (clone A20) eBiosciences Cat#17-0453-81
Mouse anti mouse CD45.2 (clone 104) eBiosciences Cat#12-0454-81
Rat anti mouse CD8 (clone 53-6.7) Biolegend Cat#100706
Rat anti mouse CD19 (clone 6D5) Biolegend Cat#115538
Rat anti mouse SiglecF (clone E50-2440) BD PharMingen Cat#562681
Rat anti mouse Ly6G (clone 1A8) Biolegend Cat#127628
Rat anti mouse CD3 (clone 17A2) Biolegend Cat#100228
Mouse anti mouse CD64 (clone X54-5/7.1) Biolegend Cat#139306
Rat anti mouse Ly6C (clone HK1.4) Biolegend Cat#128024
Armenian Hamster anti mouse CD11c (clone N418) Biolegend Cat#117334
Rat anti CD11b (clone M1/70) Biolegend Cat#101241
Rat anti mouse F4/80 (clone BM8) eBiosciences Cat#25-4801-82
Rat anti mouse MHCII (I-A/I-E) (clone M5/114.15.2) eBiosciences Cat#47-5321-82
Rat anti mouse CD90.2 (clone 30-H12) Biolegend Cat#105308
Armenian Hamster anti mouse FcεR1 (clone MAR-1) Biolegend Cat#134309
Mouse anti mouse NK-1.1 (clone PK136) Biolegend Cat#108710
Mouse anti EGF-R (clone EGF-R1) Abcam Cat#Ab30
Rat anti mouse IL-13 (clone eBio13A) eBiosciences Cat#50-7133-80
Rat anti mouse IL-4 (clone 11B11) Biolegend Cat#504104
Rat anti IL-5 (clone TRFK5) BD PharMingen Cat#554395
Rat anti mouse IFN-g (clone XMG1.2) Biolegend Cat#505806
Rabbit polyclonal anti p-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Cell Signaling Cat#9101
Mouse anti IkBa (clone L35A5) Cell Signaling Cat#4814
Rabbit polyclonal anti p-EGFR (Tyr1068) Cell Signaling Cat# (D7A5) XP 3777
Rabbit polyclonal anti p-EGFR (Tyr992) ThermoFisher Cat#44-786G
Rat anti FoxP3 (clone FJK-16 s) eBiosciences Cat#50-5773-82
Human anti GATA3 (clone REA174) Miltenyi Biotec Cat#130-108-061
Mouse anti c-Maf (clone sym0F1) eBioscience Cat#12-9855-41
Rat anti mouse CD8 (clone 53-6.7) BioXcell Cat#BE0004-1
Rat anti mouse B220 (clone RA3.3A1/6.1 (TIB-146)) BioXcell Cat#BE0067
Rat anti mouse CD11b (clone M1/70) BioXcell Cat#BE0007
Rat anti mouse MHCII (I-A/I-E) (clone M5/114) BioXcell Cat#BE0108
Armenian Hamster anti mouse CD3 (clone 145-2C11) BD PharMingen Cat#553058
Rabbit polyclonal anti T1/ST2 Thermo Scientific/Pierce Cat#PA5-20077
Rabbit polyclonal anti STAT6 Cell Signaling Cat#9362
Anti EGFR (clone EP38Y) Abcam Cat#ab52894
Rabbit polyclonal hEGFR Santa Cruz Biotechnology Cat#sc-03-G
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Rabbit polyclonal anti Sos Cell Signaling Cat#5890
Rabbit polyclonal anti SHP-2 Cell Signaling Cat#3752
Goat polyclonal anti hIL-33R R&D systems Cat#Baf523
Anti-hIL-1RacP R&D systems Cat#AF676
Bacterial and Virus Strains
Heligmosomoides polygyrus Camberis et al., 2003 N/A
Mouse-adapted Nippostrongylus brasiliensis Minutti et al., 2017 N/A
Chemicals, Peptides, and Recombinant Proteins
Brefeldin A Sigma Cat#B6542
Recombinant mouse IL-13 Immunotools Cat#12340137
Recombinant mouse IL-33 PeproTech Cat#210-33
Recombinant human HB-EGF R&D Systems Cat#259-HE
Recombinant mouse IL-7 PeproTech Cat#217-17
Recombinant mouse IL-2 BD Biosciences Cat#550069
Recombinant mouse TSLP eBiosciences Cat#34-8498-82
MEK inhibitor Promega Cat#V1121




LIVE/DEAD Fixable Blue Dead Cell Stain Kit Thermo Fisher Cat#L23105
Sheep anti-Rat IgG Dynabeads Invitrogen Cat#110.35
IL-13 Mouse ELISA Kit eBioscience Cat#88-7137-76
IL-5 Mouse ELISA Kit eBioscience Cat#88-7054-88
Deposited Data
Sequencing raw data of RNA-seq experiment GEO accession number GEO: GSE104096
Experimental Models: Cell Lines
HEK293 cells ATCC N/A
HaCaT cells ATCC N/A
Experimental Models: Organisms/Strains
EGFRflox/flox Natarajan A et al., 2007
PNAS 104:17081
N/A
CD4-Cre Taconics Stock No: 4196
FoxP3-Cre The Jackson Laboratory Stock No: 016959
Areg/ Luetteke NC et al., 1999
Development. 126:2739-50
N/A
MHCII/ (B6;129S2-H2dlAb1-Ea/J) The Jackson Laboratory Stock No: 003374
T1/ST2/ Townsend MJ et al., 2000
J Exp Med. 191:1069
N/A
IL-13/ McKenzie et al., 1998 N/A
Oligonucleotides
Primer for Il13 mRNA Applied Biosystems Cat#Mm00434204
Primer for Il5 mRNA Applied Biosystems Cat#Mm00439646
Primer for Il4 mRNA Applied Biosystems Cat#Mm00445259
Primer for Cd3e mRNA Applied Biosystems Cat#Mm00599684
Primer for Muc5ac mRNA Applied Biosystems Cat#Mm01276718
Primer for Areg mRNA Applied Biosystems Cat#Mm00437583
Primer for Rn18s mRNA Applied Biosystems Cat#Mm03928990
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Breeding of experimental animals
C57BL/6J mice (wt, Egfrflox/flox, Cd4-cre x Egfrflox/flox, Foxp3-cre x Egfrflox/flox, Areg/ and MHCII-deficient Ab/) were bred and
maintained at the University of Edinburgh, Trinity College Dublin (T1/ST2-deficient Il1rl1/) or the Laboratory of Molecular Biology,
Cambridge (Il13/) in specific-pathogen free conditions. Sex-matched mice were 6-8-weeks old at the start of the experiment, and
all mice were housed in individually ventilated cages. Mice were not randomized in cages, but each cagewas randomly assigned to a
treatment group. Investigators were not blinded to mouse identity during necropsy but during worm and egg counts. Experiments
were performed in accordance with the United KingdomAnimals (Scientific Procedures) Act of 1986. All researchers were accredited
by the UK government Home Office. Dispensation to carry out animal research at The University of Edinburgh was approved by the
University of Edinburgh Animal Welfare and Ethical Review Body and granted by the UK government Home Office; as such all
research was carried under the project licenses PPL70/8470 and 70/8483. All animal experiments in Ireland were performed under
license in compliance with the Health Products Regulatory Authority and approved by the Trinity College Dublin’s BioResources
ethical review board. Note: Male and female mice were used to perform the experiments shown in this manuscript. However,
none of the experiments were conducted using both sexes at the same time. We never observed an obvious difference between
sexes within the parameters analyzed for our experiments.
METHOD DETAILS
Splenocyte cultures
Single cell suspensions of spleens were obtained by forcing the tissue through a 70 mMcell strainer. Subsequently, cells were treated
with red blood cell lysis buffer (Sigma-Aldrich) and counted using an automated cellometer T4 (Peqlab, Radnor, PA). In some
experiments, T helper cells were sorted based on CD3 and CD4 positivity and different T cell subpopulations were sorted as
indicated. Cells were incubated in IMDM medium supplemented with 10% FCS, 1% l-glutamine, 1% penicillin/streptomycin and
5 3 105 M 2-mercaptoethanol at 37C in a humidified atmosphere at 5% CO2.
Cell Lines
HEK293 cells and HaCaT cells were cultured in IMDM medium supplemented with 10% FCS, 1% l-glutamine, 1% penicillin/strep-
tomycin and 5 3 105 M 2-mercaptoethanol at 37C in a humidified atmosphere at 5% CO2.
Nematode infections, de-worming and IL-13 delivery
H. polygyrus and mouse-adapted N. brasiliensis were maintained by serial passage trough F1 (C57BL/6xCBA) and C57BL/6 mice
respectively, as described previously (Camberis et al., 2003; Minutti et al., 2017). Mice were infected by oral gavage with 200
H. polygyrus and subcutaneously with 250 N. brasiliensis third-stage larvae. For deworming, mice were treated orally with pyrantel
embonate in the form of 2.5 mg Strongid P paste (Pfizer) in 0.2 mL water on day 14 post-primary infection (Hewitson et al., 2011). In
IL-13 delivery experiments, 5 mg of rmIL-13 (Immunotools) was injected intra-peritoneally at days 6, 7 and 8 post H. polygyrus infec-
tion. Egg output was analyzed in faeces and adult worm burdens were determined by removing the small intestine and exposing the
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In vivo delivery of Brefeldin A and duodena digestion
In vivo delivery of Brefeldin A was performed as previously described (Liu andWhitton, 2005). Briefly, Brefeldin A (Sigma) was resus-
pended at 20mg/ml in DMSO. Further dilution to 1mg/ml wasmade in PBS, and 250 mLwere injected i.v.. 6 hours later duodenawere
harvested and intestial-resident leukocytes were purified by two sequantial pre-digestions (20 mins, at 37C) with HBSS containing:
10 mM HEPES, 5 mM EDTA, 1 mM DTT and 5% FCS in the presence or absence of Monensin (Invitrogen) (10 mM). After,
samples were digested for 30mins at 37Cwith HBSS containing 10mMHEPES, 0.5mg/mLCollagenase D, 0.5mg/mLDNase I grade
II, 3 mg/mL Dispase II (Roche) and 5% FCS. Single cell suspensions were prepared by forcing the samples through a 70-mm cell
stainer and subsequent washes.
Flow Cytometry and FACS-sorting
Cells were incubated with Fc block (CD16/CD32 and 10%mouse serum) and stained with a combination of the following commercial
monoclonal fluorescently conjugated antibodies (clone, brand and catalog no. specified in the KEY RESOURCES TABLE): CD4,
CD69, T1/ST2, CD62L, CD44, CD45Rb, CD25, CD45.1, CD45.2, CD8, CD19, SiglecF, Ly6G, CD3, CD64, Ly6C, CD11c, CD11b,
F4/80, I-A/I-E (MHCII), CD90.2, FcεR1, NK-1.1 and EGF-R. For intracellular staining, cells were fixed with 2% paraformaldehyde
in dPBS for 20 min at room temperature, permeabilized with 0.5% Saponin or ice-cold methanol then stained with IL-13, IL-4,
IL-5, IFN-g, p-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), IkBa, p-EGFR (Tyr1068), p-EGFR (Tyr992) or isotype control followed by
anti-Rabbit IgG secondary antibodies (Invitrogen). For detection of FoxP3, GATA3 and c-Maf cells were stained for surface markers
then fixed and permeabilized using FoxP3 staining buffer set (eBioscience). Cells were then stainedwith FoxP3, GATA3 and c-Maf for
30 min at room temperature. Live/Dead (Life Technologies) was used to exclude dead cells from analysis. Samples were analyzed by
flow cytometry using Becton Dickinson FACS LSR II and FlowJo software. Alveolarmacrophages were identified as described before
(Minutti et al., 2017): lineage negative– (CD19–, Ly6G– and CD3–), CD64+, CD11c+ and SiglecF+. ILC2 cells were identified as
described before (Monticelli et al., 2015), detailed gating strategy is shown in Figure S4E.
For some experiments, T cells from mLN of infected mice were enriched (as described below) and subsequently stained with a
combination of antibodies to CD3, CD4, CD69, T1/ST2, CD62L, CD44, CD45Rb, CD25 and EGF-R prior to sorting on a FACS Aria
(BD). T helper cells were sorted based on CD3 and CD4 positivity and different T cell subpopulations were sorted as indicated.
T cell purity was verified by flow cytometry.
RNA extraction and quantitative real-time PCR
Tissue was homogenized in TRIzol with a TissueLyser (QIAGEN) and RNA was isolated following manufacturer’s instructions.
Reverse transcription was performed using 1 mg of total RNA using 200 U of M-MLV reverse transcriptase, 10 mM dNTPs, and
0.5 mg Oligo dT15 and RNasin inhibitor (Promega). Expression of genes of interest was measured by real-time PCR with the Light-
cycler 480 II system (Roche) using TaqmanMaster kit and specific primers (specified in the KEY RESOURCES TABLE), as previously
described (Meulenbroeks et al., 2015). PCR amplification was analyzed using 2nd derivativemaximum algorithm (LightCycler 480 Sw
1.5, Roche) and the expression of the gene of interest was normalized to the housekeeping gene Rn18s.
T cell enrichment and adoptive transfer experiments
For transfer experiments, mLN were collected from donor mice 14 days after H. polygyrus infection. mLN single cell suspensions
were prepared by forcing through a 70uM cell strainer and the homogenates were treated to lysate red blood cells. For transfer of
CD4+ T cells, these cells were purified by negative selection using Sheep anti-Rat IgG Dynabeads (Invitrogen) and monoclonal
antibodies (specified in the KEY RESOURCES TABLE) to CD8, B220, CD11b and I-A/I-E (MHCII) following manufacturer’s protocol.
Approximately 1.5 x106 Cells were transferred intravenously. In some experiments, CD4+ T cell subpopulations were further purified
by FACS-sorting prior to intra-venous transfer, in this case approximately 1 x105 cells were transferred. All recipients received the
same percentage of Th2 cells as determined by the analysis of GATA3 expression and/or IL-13 expression by re-stimulated CD4+
T cells.H. polygyrus-infected recipient mice received transferred cells on day 7 post-infection whereas N. brasiliensis-infected recip-
ients mice received transferred cells at the same time of infection.
For the generation of resting T cells, donor mice were infected with H. polygyrus and two weeks after infection the mice were dew-
ormed by oral deliver of pyrantel embonate in the form of 2.5 mg Strongid P paste in 0.2 mL water. After two weeks of deworming
treatment mLNs were harvested and T cells were enriched as described above. Ova-specific activated and memory T cells were
generated with nebulised ovalbumin. In brief, animals were immunized twice by an intra-peritoneal injection of 10ug of OVA
(Sigma-Aldrich) dissolved in alum, with a break of two weeks between each immunization. Seven days following the second immu-
nisation, mice were nebulised for 20 minutes on 5 consecutive days, with either PBS only, or with PBS containing 100ug/ml of ova, at
a rate of 1ml/minute. Thoracic lymph nodes (parathymic, posterior, mediastinal and paravertebral LN) were collected 24 h or 1month
following the last treatment to isolate activated or memory CD4+ T cells, respectively. T cells were FACS sorted and transferred as
indicated with or without concomitant ip. delivery of ova/alum or adjuvant only.
Th2 cells generation and RNaseq analysis
CD4+ CD25 CD45Rbhi cells were FACS-sorted from spleens of wt and EGFRDCD4 mice and cultured in IMDM medium supple-
mented with 10% FCS, 1% l-glutamine, 1% penicillin/streptomycin and 5 3 105 M 2-mercaptoethanol. Th2 cells were generatede4 Immunity 47, 710–722.e1–e6, October 17, 2017
by adding IL-2 (1 ng/mL), IL-4 (2 ng/ml) and neutralizing IFN-g antibody (clone R4.6A2, 5 mg/mL) into the culture. RNA was isolated
using the RNeasy Mini Kit (QUIAGEN Cat. No. 74104). RNA seq data are deposited under GEO accession number: GSE104096.
Immunoprecipitation on T cells
CD4+ T cells were enriched by negative selection using Sheep anti-Rat IgG Dynabeads as described above. Purified T cells were
stimulated with IL-33 (PeproTech) (10 ng/mL) or vehicle for 1 hour. After culture, cells were lysed at 4C for 30 min in 500 mL of lysis
buffer containing: 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.05% Sodium azide and 1 mM phenylmethyl-
sulfonyl fluoride (PMSF). The lysates were centrifuged at 10 000 3 g for 10 min, and the supernatants were pre-cleared by adding
protein A-Sepharose (50 mL) and incubated at 4C for 1 hour, followed by centrifugation at 10 000 3 g for 10 min. The pre-cleared
supernatant was incubated with anti-T1/ST2 antibody (Thermo Scientific/Pierce, 10ug/ml) or control IgG at 4Covernight, after which
50 mL of protein A-Sepharose was added for 4 h at 4Cwith gentle rotation. The immune complexes were collected by centrifugation
at 10 000 3 g for 5 min at 4C, washed three times with cold lysis buffer, and released by boiling with 5 3 Laemmli loading buffer.
Western blots
Cell lysates and samples from co-immunoprecipitation assays were resolved by 8% (m/v) SDS-PAGE in reducing conditions and
transferred to nitrocellulose membranes. After blocking with 2% BSA, membranes were washed and incubated with an anti-
Stat6, EGFR or T1/ST2 antibodies (brand and catalog no. specified in the KEY RESOURCES TABLE) overnight at 4C. The mem-
branes were washed and incubated with horseradish-peroxidase-labeled secondary antibodies for 1 hour at room temperature
and exposed to ECL reagents.
HEK293T transfection and immunoprecipitation
HEK293T cells (0.8 x106 cells/sample) were seeded in DEMEM (Sigma) supplemented with 10% FCS but w/o antibiotics. Cells were
incubated overnight (according to the lipofectamin transfection protocol). Cells were transfected with pcDNA3-hIL-33R, pcDNA3-
hIL-1RacP, pRK5-wt-hEGFR or pRK5-hY992F-EGFR (1.3mg DNA/sample of each construct) (pRK5-wt-hEGFR and pRK5-
hY992F-EGFR were kindly provided by Prof. Dr. F.-D. Bo¨hmer; Department for Moleculare Cell biology, Jena) by using lipofectamin
(Invitrogen) according to the manufacturer procedures. To obtain the same DNA content in every sample (total 4mg DNA/sample),
single- and co-transfections were filled with empty vector (pcDNA3). Subsequently, HEK293T cells were incubated for 24h. After-
ward, cells were lysed (with Lysis buffer containing: 20 mM HEPES, pH7.5; 10 mM EDTA; 40 mM b-glycerophosphate; 2,5 mM
MgCl2; 2 mM orthovanadate; 1 mM dithiothreitol; 20 mg/ml aprotinin; 20 mg/ml leupeptin supplemented with 0,5% NP40). Protein
concentration was determined by using the BCA-kit (Pierce). A small aliquot of every sample was taken to perform the input blot.
Thereby, samples were treated and boiled in 6 x Laemmli buffer. Samples were analyzed by SDS-PAGE (8%) and western blotting
by using the anti-hEGFR, the anti-Sos, the anti-Shp2, the anti-hIL-33R and the anti-hIL-1RacP antibodies (brand and catalog no.
specified in the KEY RESOURCES TABLE). The rest of the samples were subjected to anti-hEGFR-specific or to an isotype (as
non-specific goat control immunoglobulins; Gentaur) immunprecipitation overnight. Samples were treated with Protein-G sepharo-
ses (invtrogen) for 4-6h. Precipitates were washed with Lysisbuffer and PBS, and were treated and boiled in 6 x Laemmli buffer.
Immunoprecipitated samples were analyzed by SDS-PAGE (8%) and western blotting by using anti-hEGFR, anti-Sos, anti-Shp2,
anti-hIL-33R and anti-hIL-1RacP antibodies. As secondary antibodies for all western blots we used anti-rabbit-POD (for the detection
of hEGFR, Sos, Shp2 and hIL-1Racp) (Santa Cruz Biotechnology). For detection of the hIL-33Rwe a used anti-goat-POD (Santa Cruz
Biotechnology) or POD-coupled streptavidine (Roche). Membranes were developed with the ECL-reagent (Pierce).
Cytokine and H. polygyrus antigen ELISA
Mouse IL-13 and IL-5 were measured according to manufacturers instructions using ELISA Kits (eBioscience). H. polygyrus antigen
(HEX; Finney et al., 2007) was prepared by homogenizing adult worms in PBS, which was centrifuged (13 000 3 g, 10 min); the su-
pernatant was filtered (0.2 mm) and stored at 1.5mg/mL at –80C. Antigen-specific antibody responses were determined by ELISA as
described before (Finney et al., 2007). Multisorp (Nunc) plates were coated with 5 mg/mL H. polygyrus antigen in 0.06 M carbonate
buffer pH 9.6, overnight at 4C. Plates were blocked with 5%BSA for 2 h at 37C. Faecal homogenates and sera were diluted in TBS/
0.05% Tween and added to wells overnight at 4C. Antigen-specific Ig isotypes were detected with HRP-conjugated detecting an-
tibodies (Southern Biotechnology), with TMB peroxidase substrate.
Ex vivo re-stimulation conditions
To determine the induction of cytokines expression, FACS-sorted T cells and mLN cells or splenocytes were cultured in 96-well
plates in IMDMmedium, 10%FCS, 1% l-glutamine, 1% penicillin/streptomycin (GIBCO), 53 105 M 2-mercaptoethanol in the pres-
ence or absence of Monoensin (Invitrogen) (10 mM) and rmIL-33 (PeproTech) (10 ng/mL) or anti-CD3 (BD, 145-2C11) (2 mg/mL) for six
hours. Alternatively, intracellular amounts of p-EGFR (Y1068 and Y992), p-ERK and IkBa were analyzed after 30 minutes of stimu-
lation with IL-33 (10 ng/mL), anti-CD3 (2 mg/mL), AREG (R&D) (10 ng/mL) or HB-EGF (R&D) (10 ng/mL). To analyze EGFR or
AREG induction, splenocytes or FACS-sorted T cells were re-stimulated overnight with H. polygyrus excretory-secretory products
(HES; Johnston et al., 2015) (1 mg/mL), adult worm extract (HEX) (10 mg/mL), anti-CD3 (2 mg/mL), IL-7 (PeproTech) (20 ng/mL),
IL-2 (BD) (1 ng/mL), TSLP (eBiosciences) (20 ng/mL) and IL-33 (10 ng/mL). Inhibitors were used at the following concentrations:
MEK inhibitor (Promega)(10 mM), Gefitinib (LC laboratories) (1 mM) and Marimastat (AbCam) (25 mM). The inhibitory effect ofImmunity 47, 710–722.e1–e6, October 17, 2017 e5
Marimastat (25 mM) was checked by its ability to prevent the release of activated Amphiregulin by transfected HEK cells. Under these
conditions cell viability was higher than 90% as compared to 97% at the start of the experiment.
QUANTIFICATION AND STATISTICAL ANALYSIS
Normal distribution of data was determined by visual examination of residuals. Statistical evaluation of different groups was per-
formed either by analysis of variance (ANOVA) followed by the Turkey multiple comparison test or by non-parametric Mann-Whitney
test, as indicated. An a threshold % 5% (p % 0.05) was considered significant. All statistical calculations were performed using
PRISM, (Graphpad, La Jolla, CA).
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq dataset reported in this paper is GEO: GSE104096.e6 Immunity 47, 710–722.e1–e6, October 17, 2017
